Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa by Dassaye, R, Wand, H, Reddy, T, Tanser, F, Sartorius, B, Morris, N, Ramjee, G

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy by Stöhr, W, Fidler, S, McClure, M, Weber, J, Cooper, D, Ramjee, G, Kaleebu, P, Tambussi, G, Schechter, M, Babiker, A, Phillips, R, Porter, K, Frater, J

CD32-expressing CD4 T cells are phenotypically diverse and can contain proviral HIV DNA by Martin, G, Pace, M, Thornhill, J, Phetsouphanh, C, Meyerowitz, J, Gossez, M, Brown, H, Olejniczak, N, Lwanga, J, Ramjee, G, Kaleebu, P, Porter, K, Willberg, C, Klenerman, P, Nwokolo, N, Fox, J, Fidler, S, Frater, J

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters by Gossez, M, Martin, GE, Pace, M, Ramjee, G, Premraj, A, Kaleebu, P, Rees, H, Inshaw, J, Stöhr, W, Meyerowitz, J, Hopkins, E, Jones, M, Hurst, J, Porter, K, Babiker, A, Fidler, S, Frater, J, Spartac Trial Investigators

Short-course antiretroviral therapy in primary HIV infection. by Fidler, S, Porter, K, Ewings, F, Frater, J, Ramjee, G, Cooper, D, Rees, H, Fisher, M, Schechter, M, Kaleebu, P, Tambussi, G, Kinloch, S, Miro, J, Kelleher, A, McClure, M, Kaye, S, Gabriel, M, Phillips, R, Weber, J, Babiker, A